|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
CA2472404A1
(en)
|
1993-07-19 |
1995-02-02 |
Angiotech Pharmaceuticals, Inc. |
Combination of stent and anti-angiogenic factor
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
US5415869A
(en)
*
|
1993-11-12 |
1995-05-16 |
The Research Foundation Of State University Of New York |
Taxol formulation
|
|
US5833891A
(en)
|
1996-10-09 |
1998-11-10 |
The University Of Kansas |
Methods for a particle precipitation and coating using near-critical and supercritical antisolvents
|
|
US5874029A
(en)
|
1996-10-09 |
1999-02-23 |
The University Of Kansas |
Methods for particle micronization and nanonization by recrystallization from organic solutions sprayed into a compressed antisolvent
|
|
DE69734060T2
(de)
|
1996-05-24 |
2006-06-29 |
Angiotech Pharmaceuticals, Inc., Vancouver |
Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
|
|
US5756537A
(en)
|
1996-11-08 |
1998-05-26 |
Parkash S. Gill, M.D., Inc. |
Regime for paclitaxel in Kaposi's sarcoma patients
|
|
US6515016B2
(en)
*
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
|
US6495579B1
(en)
|
1996-12-02 |
2002-12-17 |
Angiotech Pharmaceuticals, Inc. |
Method for treating multiple sclerosis
|
|
PT1023050E
(pt)
|
1997-06-27 |
2013-12-04 |
Abraxis Bioscience Llc |
Novas formulações de agentes farmacológicos, métodos para a sua preparação e métodos para a sua utilização
|
|
US6004573A
(en)
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
US6117949A
(en)
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
|
IL131217A0
(en)
|
1998-03-10 |
2001-01-28 |
Napro Biotherapeutics Inc |
Novel methods and compositions for delivery of taxanes
|
|
US8293277B2
(en)
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
US6113795A
(en)
|
1998-11-17 |
2000-09-05 |
The University Of Kansas |
Process and apparatus for size selective separation of micro- and nano-particles
|
|
IN191203B
(https=)
|
1999-02-17 |
2003-10-04 |
Amarnath Prof Maitra |
|
|
US6365191B1
(en)
|
1999-02-17 |
2002-04-02 |
Dabur Research Foundation |
Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
|
|
US6406722B1
(en)
|
1999-02-18 |
2002-06-18 |
Robert G. Gallaher |
Method of treating viral infections and lesions with taxane compounds
|
|
US7217735B1
(en)
|
1999-04-09 |
2007-05-15 |
Au Jessie L-S |
Methods and compositions for enhancing delivery of therapeutic agents to tissues
|
|
NZ516083A
(en)
|
1999-05-27 |
2003-08-29 |
Acusphere Inc |
Porous drug matrices and methods of manufacture thereof
|
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
|
US6892091B1
(en)
|
2000-02-18 |
2005-05-10 |
Biosense, Inc. |
Catheter, method and apparatus for generating an electrical map of a chamber of the heart
|
|
CA2410632A1
(en)
|
2000-06-22 |
2001-12-27 |
David S. Garvey |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
|
US8178123B2
(en)
|
2001-08-29 |
2012-05-15 |
Femina Pharma Incorporated |
Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration
|
|
CN1592607A
(zh)
|
2001-10-15 |
2005-03-09 |
克里蒂泰克公司 |
水溶性差药物的组合物、其给药方法和治疗方法
|
|
US20080220075A1
(en)
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
WO2003080027A1
(en)
|
2002-03-20 |
2003-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
|
KR100533458B1
(ko)
*
|
2002-07-20 |
2005-12-07 |
대화제약 주식회사 |
파클리탁셀의 가용화용 조성물 및 그의 제조 방법
|
|
WO2004098570A1
(en)
*
|
2002-10-30 |
2004-11-18 |
Spherics, Inc. |
Nanoparticulate bioactive agents
|
|
CA2509365C
(en)
|
2002-12-09 |
2012-08-07 |
American Bioscience, Inc. |
Compositions and methods of delivery of pharmacological agents
|
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
|
FR2856301B1
(fr)
|
2003-06-23 |
2007-08-03 |
Galderma Res & Dev |
Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
|
|
US9149440B2
(en)
|
2003-09-02 |
2015-10-06 |
University Of South Florida |
Nanoparticles for drug-delivery
|
|
WO2005039533A1
(en)
|
2003-10-15 |
2005-05-06 |
Medigene Ag |
Method of administering cationic liposomes comprising an active drug
|
|
EP1686962B9
(en)
|
2003-11-05 |
2012-10-03 |
Elan Pharma International Limited |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
|
FR2862540B1
(fr)
|
2003-11-21 |
2007-03-30 |
Galderma Res & Dev |
Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
|
|
FR2871695B1
(fr)
|
2004-06-17 |
2008-07-04 |
Galderma Sa |
Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
|
|
FR2871697B1
(fr)
|
2004-06-17 |
2007-06-29 |
Galderma Sa |
Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
|
|
US7361683B2
(en)
|
2004-11-24 |
2008-04-22 |
Yung Shin Pharm. Ind., Co., Ltd |
Paclitaxel aqueous injection solution and methods for preparing the same
|
|
US8062658B2
(en)
|
2004-12-14 |
2011-11-22 |
Poly-Med, Inc. |
Multicomponent bioactive intravaginal ring
|
|
JP2008531591A
(ja)
|
2005-02-24 |
2008-08-14 |
エラン・ファルマ・インターナショナル・リミテッド |
ドセタキセルおよびそれらの類似体のナノ粒子製剤
|
|
GB0506139D0
(en)
|
2005-03-24 |
2005-05-04 |
Transphase Ltd |
A transdermal topical composition and its uses
|
|
CA2609927A1
(en)
|
2005-04-27 |
2006-11-02 |
Leiden University Medical Center |
Methods and means for the treatment of hpv induced intraepithelial neoplasias
|
|
US20090304803A1
(en)
|
2005-06-06 |
2009-12-10 |
The General Hospital Corporation |
Compositions and methods relating to target-specific photodynamic therapy
|
|
EP3527202A1
(en)
|
2005-08-31 |
2019-08-21 |
Abraxis BioScience, LLC |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
|
RU2008128451A
(ru)
|
2005-12-14 |
2010-01-20 |
Огенодженесис, Инк. (US) |
Композиция для лечения и ухода за кожей, способ ее получения, способ ее использования
|
|
US8906392B2
(en)
|
2005-12-16 |
2014-12-09 |
University Of Kansas |
Nanocluster compositions and methods
|
|
US8343962B2
(en)
|
2006-03-06 |
2013-01-01 |
Nuvo Research Inc. |
Topical formulation
|
|
US7744923B2
(en)
|
2006-10-11 |
2010-06-29 |
Crititech, Inc. |
Method for precipitation of small medicament particles into use containers
|
|
US8414909B2
(en)
*
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
|
CA2611803C
(en)
|
2006-11-22 |
2013-03-19 |
Bj Services Company |
Well treatment fluid containing viscoelastic surfactant and viscosification activator
|
|
EP3470071A1
(en)
|
2006-12-14 |
2019-04-17 |
Abraxis BioScience, LLC |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
|
TWI405590B
(zh)
|
2007-04-06 |
2013-08-21 |
活效製藥股份有限公司 |
微粉碎化有機化合物粒子之製法
|
|
JP5579057B2
(ja)
|
2007-06-01 |
2014-08-27 |
アブラクシス バイオサイエンス, エルエルシー |
再発性癌の処置のための方法および組成物
|
|
ITMI20071267A1
(it)
|
2007-06-22 |
2008-12-23 |
Fidia Farmaceutici |
Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative
|
|
HU227970B1
(en)
|
2007-07-10 |
2012-07-30 |
Egis Gyogyszergyar Nyrt |
Pharmaceutical compositions containing silicones of high volatility
|
|
CN101129338A
(zh)
|
2007-08-27 |
2008-02-27 |
四川大学 |
超临界流体新技术微细化抗癌药物紫杉醇
|
|
DK2200588T3
(da)
*
|
2007-09-25 |
2019-07-01 |
Solubest Ltd |
Sammensætninger, som omfatter lipofile aktive forbindelser, og fremgangsmåde til fremstilling deraf
|
|
EP2222278B1
(en)
|
2007-11-28 |
2015-04-08 |
Celator Pharmaceuticals, Inc. |
Improved taxane delivery system
|
|
WO2009072007A2
(en)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
|
|
US8865194B1
(en)
|
2007-12-20 |
2014-10-21 |
Theraplex Company, LLC |
Reducing tackiness and greasiness of petrolatum-like materials
|
|
US20090175810A1
(en)
|
2008-01-03 |
2009-07-09 |
Gareth Winckle |
Compositions and methods for treating diseases of the nail
|
|
US8952075B2
(en)
|
2008-05-22 |
2015-02-10 |
Poly-Med, Inc. |
Bioactive polymeric liquid formulations of absorbable, segmented aliphatic polyurethane compositions
|
|
TW200942233A
(en)
*
|
2008-04-10 |
2009-10-16 |
Abraxis Bioscience Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
WO2009153774A2
(en)
*
|
2008-06-17 |
2009-12-23 |
Rosetta Genomics Ltd. |
Compositions and methods for prognosis of ovarian cancer
|
|
KR101848095B1
(ko)
|
2008-06-26 |
2018-04-11 |
안테리오스, 인코퍼레이티드 |
경피 운반
|
|
WO2011022652A1
(en)
|
2009-08-21 |
2011-02-24 |
Novan, Inc. |
Topical gels
|
|
WO2011064631A1
(en)
|
2009-10-02 |
2011-06-03 |
Foamix Ltd. |
Surfactant-free, water-free, foamable compositions and breakable foams and their uses
|
|
GB2474930B
(en)
*
|
2009-10-02 |
2012-07-04 |
Foamix Ltd |
Topical tetracycline compositions
|
|
CA2777397C
(en)
|
2009-10-13 |
2017-08-29 |
Rexahn Pharmaceuticals, Inc. |
Polymeric systems for the delivery of anticancer agents
|
|
CN101829061A
(zh)
*
|
2010-05-14 |
2010-09-15 |
无锡纳生生物科技有限公司 |
一种紫杉醇纳米颗粒组合物及其制备方法
|
|
CN101843582B
(zh)
*
|
2010-05-18 |
2011-12-21 |
南京工业大学 |
紫杉醇纳米混悬剂及其制备方法
|
|
WO2011151418A2
(en)
*
|
2010-06-02 |
2011-12-08 |
Abbott Gmbh & Co. Kg |
Nanosusupension formulation comprising a polydimethylsiloxane hydrophobic phase
|
|
US8039494B1
(en)
|
2010-07-08 |
2011-10-18 |
Dow Pharmaceutical Sciences, Inc. |
Compositions and methods for treating diseases of the nail
|
|
WO2012013229A1
(en)
|
2010-07-28 |
2012-02-02 |
Fondazione Irccs |
Therapeutic agent, composition including said agent, implantable device and process for the treatment of cervical cancer and/or for the prevention of the formation of neoplasms in correspondence of the cervix in a human female genital system.
|
|
WO2012017349A2
(en)
|
2010-08-02 |
2012-02-09 |
Ranbaxy Laboratories Limited |
An improved topical pharmaceutical composition comprising nanonized silver sulfadiazine
|
|
US8563535B2
(en)
|
2011-03-29 |
2013-10-22 |
Kamal Mehta |
Combination composition comprising benzoyl peroxide and adapalene
|
|
WO2012130314A1
(en)
|
2011-03-31 |
2012-10-04 |
Elara Pharmaceuticals Gmbh |
Composition comprising docetaxel
|
|
WO2012135422A2
(en)
|
2011-04-01 |
2012-10-04 |
University Of Florida Research Foundation, Inc. |
Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
|
|
AU2012251135A1
(en)
|
2011-05-02 |
2013-11-07 |
Lipidor Ab |
Treatment of psoriasis
|
|
BR112013033466A8
(pt)
|
2011-06-27 |
2018-03-06 |
Cristal Delivery B V |
uso de um sistema de liberação controlada e sistema de liberação controlada
|
|
US9018246B2
(en)
|
2012-09-05 |
2015-04-28 |
Lp Pharmaceutical (Xiamen) Co., Ltd. |
Transmucosal administration of taxanes
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
JP2014114249A
(ja)
|
2012-12-11 |
2014-06-26 |
Kanae Technos:Kk |
基剤、及び皮膚外用剤
|
|
US8778181B1
(en)
|
2013-03-14 |
2014-07-15 |
Crititech, Inc. |
Equipment assembly for and method of processing particles
|
|
EP2978420A4
(en)
|
2013-03-28 |
2016-12-21 |
Bbs Nanotechnology Ltd |
STABLE NANO COMPOSITION WITH DOXORUBICIN, PROCESS FOR THE PREPARATION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH
|
|
AU2014302215A1
(en)
*
|
2013-06-28 |
2016-01-21 |
Pfizer Inc. |
Docetaxel polymeric nanoparticles for cancer treatment
|
|
TWI601542B
(zh)
|
2014-04-18 |
2017-10-11 |
林信湧 |
一種用於治療肺癌之吸入式醫藥組成物及其備製方法
|
|
US20150342872A1
(en)
|
2014-06-01 |
2015-12-03 |
Crititech, Inc. |
Use of Paclitaxel Particles
|
|
WO2016071365A1
(en)
|
2014-11-03 |
2016-05-12 |
Spherium Biomed, S.L. |
Topical pharmaceutical compositions of paclitaxel
|
|
CA3026454C
(en)
|
2015-06-04 |
2023-07-04 |
Crititech, Inc. |
Collection device and methods for use
|
|
ES3055492T3
(en)
|
2015-09-16 |
2026-02-12 |
Dfb Soria Llc |
Delivery of drug nanoparticles and methods of use thereof
|
|
EP3854381A1
(en)
|
2016-04-04 |
2021-07-28 |
Crititech, Inc. |
Methods for solid tumor treatment
|
|
WO2018170196A1
(en)
|
2017-03-15 |
2018-09-20 |
Dfb Soria, Llc |
Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
|